Carlos Van Mieghem
Overview
Explore the profile of Carlos Van Mieghem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
den Dekker W, Elscot J, Bennett J, Schotborgh C, van der Schaaf R, Sabate M, et al.
JACC Cardiovasc Interv
. 2024 Dec;
17(24):2866-2874.
PMID: 39722269
Background: In patients with acute coronary syndromes (ACS) and multivessel coronary disease, immediate complete revascularization was noninferior to staged complete revascularization for the primary composite outcome at 1 year. The...
2.
Bringmans T, Benedetti A, Zivelonghi C, Vanhaverbeke M, Mathieu F, Palmers P, et al.
Am J Cardiol
. 2024 Sep;
231:32-39.
PMID: 39241975
Coronary function testing (CFT) plays a pivotal role in the diagnosis of coronary vascular dysfunction and providing patients with tailored therapy. The Belgian registry on CFT (BELmicro registry) is a...
3.
Elscot J, Kakar H, Scarparo P, den Dekker W, Bennett J, Schotborgh C, et al.
JACC Cardiovasc Interv
. 2024 Mar;
17(6):771-782.
PMID: 38538172
Background: Complete revascularization of the culprit and all significant nonculprit lesions in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and multivessel disease (MVD) reduces major adverse cardiac events, but...
4.
Diletti R, den Dekker W, Bennett J, Schotborgh C, van der Schaaf R, Sabate M, et al.
Lancet
. 2023 Mar;
401(10383):1172-1182.
PMID: 36889333
Background: In patients with acute coronary syndrome and multivessel coronary disease, complete revascularisation by percutaneous coronary intervention (PCI) is associated with improved clinical outcomes. We aimed to investigate whether PCI...
5.
Bor W, de Veer A, Olie R, Rikken S, Chan Pin Yin D, Herrman J, et al.
EuroIntervention
. 2022 Apr;
18(4):e303-e313.
PMID: 35370126
Background: For patients on oral anticoagulants (OAC) undergoing percutaneous coronary intervention (PCI), European guidelines have recently changed their recommendations to dual antithrombotic therapy (DAT; P2Y inhibitor and OAC) without aspirin....
6.
Logghe Y, van Hoe L, Vanhoenacker P, Bladt O, Simons P, Kersschot E, et al.
Open Heart
. 2020 May;
7(1).
PMID: 32385115
Objectives: CT coronary angiography (CTCA) has become a valuable diagnostic test in the workup of patients with possible coronary artery disease (CAD). Because of inherent limitations in spatial resolution, epicardial...
7.
Dhont S, de Niel C, Van Mieghem C
Acta Cardiol
. 2019 Sep;
75(7):693-694.
PMID: 31536466
No abstract available.
8.
Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, et al.
EuroIntervention
. 2019 Jul;
15(11):e999-e1005.
PMID: 31270037
Aims: The aim of this study was to assess prospectively the clinical benefits of fractional flow reserve (FFR) in guiding coronary artery bypass grafting (CABG). Methods And Results: GRAFFITI is...
9.
de Mey N, Cammu G, Brandt I, Belmans A, Van Mieghem C, Foubert L, et al.
Anaesth Intensive Care
. 2019 Jun;
47(3):255-266.
PMID: 31165618
No abstract available.
10.
Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, et al.
J Cardiovasc Transl Res
. 2018 Jul;
11(4):269-273.
PMID: 30027499
Trial Registration: NCT01810224.